These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Therapeutic failure despite sensitive germs]. Zierler W Wien Med Wochenschr; 1968 Oct; 118(43):921-3. PubMed ID: 4973922 [No Abstract] [Full Text] [Related]
27. [Short-term chemotherapy of pulmonary tuberculosis. Pilot study]. Poppe de Figueiredo F; Brito AA; Laborne Valle JH; Tavares PM; Trannin PL Bull Int Union Tuberc; 1974; 49(1):411-7. PubMed ID: 4619561 [No Abstract] [Full Text] [Related]
28. [Effectiveness of different chemotherapy regimens with pulmonary tuberculosis patients based on the data from a comprehensive bacteriological study]. Muratov VV; Pashkov IuN; Chukanov VI Probl Tuberk; 1983 May; (5):34-8. PubMed ID: 6408636 [No Abstract] [Full Text] [Related]
30. [Short-term chemotherapy in tuberculosis. I. Preliminary results of the efficacy of antibacillary chemotherapy shortened to 6 months]. Nikodemowicz E; Kamińska M; Maternowska W; Ciezarek M; Kopeć H; Prus F; Sembratowicz L Pneumonol Pol; 1982; 50(1-2):31-7. PubMed ID: 7122248 [No Abstract] [Full Text] [Related]
31. Short-course chemotherapy for tuberculosis. Ng HK Xianggang Hu Li Za Zhi; 1984 Nov; (37):26-31. PubMed ID: 6241591 [No Abstract] [Full Text] [Related]
32. [The early diagnosis of drug allergy by biophysical methods]. Shchutskaia EI; Kolpakova TA; Priakhina VN Probl Tuberk; 1992; (11-12):62-3. PubMed ID: 1289895 [No Abstract] [Full Text] [Related]
33. [Effectiveness of alpha-tocopherol in eliminating and preventing the hepatotoxic action of tuberculostatics]. Grechin SA; Suslov EI; Mel'nik VP; Shuripa VP; Protsiuk RG Vrach Delo; 1987 Mar; (3):60-2. PubMed ID: 3590706 [No Abstract] [Full Text] [Related]
34. [Lipoprotein metabolic study of pulmonary tuberculosis during antibacterial treatment]. Liudvichek IA Probl Tuberk; 1982 Sep; (9):67-71. PubMed ID: 7145922 [No Abstract] [Full Text] [Related]
35. [Effectiveness of tuberculin and chemotherapy in destructive forms of pulmonary tuberculosis]. Stamboltsian EP; Saakian AL; Oganesian LO; Megrabian SA; Apresian EA Probl Tuberk; 1981 Apr; (4):69-70. PubMed ID: 7255378 [No Abstract] [Full Text] [Related]
36. [Results of intravenous chemotherapy in destructive pulmonary tuberculosis patients]. Ursov IG; Borovinskaia TA Vrach Delo; 1981 Feb; (2):74-7. PubMed ID: 7222618 [No Abstract] [Full Text] [Related]
37. [Cytokine-producing activity of peripheral mononuclear leukocytes in patients with pulmonary tuberculosis before and during chemotherapy]. Novitskiĭ VV; Sinitsyna VA; Voronkova OV; Strelis AK; Urazova OI; Filiniuk OV; Zemlianaia NA; Luk'ianova TA; Esimova IE Probl Tuberk Bolezn Legk; 2005; (6):39-42. PubMed ID: 16078721 [TBL] [Abstract][Full Text] [Related]
38. [Efficacy of glucocorticoids in the combined treatment of destructive pulmonary tuberculosis]. Iareshko AG Probl Tuberk; 1983 Feb; (2):44-7. PubMed ID: 6844331 [No Abstract] [Full Text] [Related]
39. [Pharmacokinetics of antitubercular preparations in the caseous necrotic sites and foci of pulmonary tuberculosis patients]. Kislitsyna NA; Kotova NI Probl Tuberk; 1981 Oct; (10):28-30. PubMed ID: 7312845 [No Abstract] [Full Text] [Related]
40. [Characteristics of infiltrative pulmonary tuberculosis located in the inferior lobe]. Andriushina KM; Borodina NV; Savenkova DI; Oliferovskaia RP Klin Med (Mosk); 1985 Dec; 63(12):48-50. PubMed ID: 3937943 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]